• <input id="ycg2u"></input>
    <legend id="ycg2u"></legend>
    <strong id="ycg2u"><u id="ycg2u"></u></strong>
  • Enable Accessibility Enable Accessibility

    Expanding Neglected Patient’s Access to Quality Diagnosis and Treatment in Disease-Endemic Countries

    Equipping facilities with safe, effective tools, training primary health workers, and supporting community awareness and behaviors.

    The Program


    Partner: DNDi (Drugs for Neglected Diseases initiative)
    Budget: 1 billion yen
    Term: 5 years
    Launch: 2019
    Area: 16 countries across Africa, Asia, and South America

    DNDi Website

    Over 1 billion people, including 500 million children, are affected by Neglected Tropical Diseases (NTDs), a group of diseases that disproportionally prevail in tropical and subtropical countries. DNDi targets five NTDs: sleeping sickness, Chagas disease, leishmaniasis, onchocerciasis and mycetoma. These are characterized by significant morbidity and/or mortality and have been prioritized due to the current limited availability and accessibility of effective diagnostic and treatment.




    Related Content